Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals

Rhea-AI Summary

Bristol Myers Squibb (BMY) has released its 2023 ESG Report, highlighting the company's commitment to environmental, social, and governance initiatives. The report emphasizes BMS's understanding that its future is interconnected with its employees, communities, and the planet. The company's ESG strategy aims to leverage its capabilities and resources to positively impact communities globally.

BMS's approach focuses on topics essential to its mission with opportunities for differentiation. The report showcases the company's progress and aspirational goals in areas beyond its core business of developing innovative medicines. This strategic focus demonstrates BMS's dedication to sustainable and responsible business practices, aligning with growing investor interest in ESG performance.

Positive

• Release of comprehensive 2023 ESG Report, demonstrating transparency and commitment to sustainability
• Strategic focus on ESG initiatives aligned with company mission, potentially enhancing brand value and stakeholder trust

Negative

• None.

NORTHAMPTON, MA / ACCESSWIRE / July 22, 2024 / Bristol Myers Squibb Company

Our Approach to ESG

At BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development and delivery of innovative medicines that help patients prevail over serious diseases. Through our ESG strategy, we seek to mobilize our capabilities and resources to positively impact the communities where we live, work and serve around the world.

Our ESG strategy is centered on topics essential to our mission with opportunity to differentiate.

To learn more, read the 2023 Bristol Myers Squibb ESG Report here

View additional multimedia and more ESG storytelling from Bristol Myers Squibb Company on 3blmedia.com.

Contact Info:
Spokesperson: Bristol Myers Squibb Company
Website: https://www.3blmedia.com/profiles/bristol-myers-squibb-company
Email: info@3blmedia.com

SOURCE: Bristol Myers Squibb Company

View the original press release on accesswire.com

FAQ

What is the focus of Bristol Myers Squibb's (BMY) 2023 ESG Report?

Bristol Myers Squibb's 2023 ESG Report focuses on the company's environmental, social, and governance initiatives, highlighting its progress and aspirational goals in areas beyond developing innovative medicines.

How does Bristol Myers Squibb (BMY) approach its ESG strategy?

BMY's ESG strategy centers on topics essential to its mission with opportunities for differentiation, aiming to mobilize its capabilities and resources to positively impact communities where it operates globally.

What is the significance of Bristol Myers Squibb's (BMY) ESG initiatives for investors?

BMY's focus on ESG initiatives demonstrates its commitment to sustainable and responsible business practices, which can enhance brand value, stakeholder trust, and potentially attract investors interested in companies with strong ESG performance.

Where can investors find more information about Bristol Myers Squibb's (BMY) ESG efforts?

Investors can access the full 2023 Bristol Myers Squibb ESG Report on the company's website or through the link provided in the press release for detailed information on BMY's ESG efforts and progress.